Strength
4 mg/24h
Manufacturer
UCB, Inc.NDC
50474080403
Classification
Brand
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
ROTIGOTINEApproval Type
New Drug (NDA)
FDA Application
NDA021829FDA Approved
5/9/2007
On Market Since
4/2/2012
Pharmacological Classes
Price Statistics
The NADAC for NEUPRO 4 MG/24 HR PATCH has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 92.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $28.3161 per EA |
|---|---|
| All-time high | $28.3555 (Sep 16, 2026) |
| All-time low | $14.7435 (Nov 28, 2013) |
| 52-week high | $28.3555 |
| 52-week low | $27.5360 |
| Median price | $22.5220 |
| Average price | $22.2095 |
| Largest weekly change | +9.9% (Jan 11, 2017) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the rotigotine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
UCB, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
rotigotine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonergot Dopamine Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEUPRO 4 MG/24 HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for NEUPRO 4 MG/24 HR PATCH, manufactured by UCB, Inc., is $28.3161 per EA (NDC 50474080403), effective Sep 30, 2026.
How has the price of NEUPRO 4 MG/24 HR PATCH changed over time?
Over the history we have for it, the NADAC for NEUPRO 4 MG/24 HR PATCH has risen 92.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEUPRO 4 MG/24 HR PATCH?
Since Nov 28, 2013, the NADAC for NEUPRO 4 MG/24 HR PATCH has ranged from a low of $14.7435 (Nov 28, 2013) to a high of $28.3555 (Sep 16, 2026), with a median of $22.5220 per EA.
Are there cheaper alternatives to NEUPRO 4 MG/24 HR PATCH?
No other NADAC-published product currently shares the active ingredient and strength of NEUPRO 4 MG/24 HR PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NEUPRO 4 MG/24 HR PATCH?
NEUPRO 4 MG/24 HR PATCH (NDC 50474080403) is labeled by UCB, Inc., and CMS classifies it as a brand product.